MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Differentiating the substantia nigra pars compacta and ventral tegmental area in early-stage Parkinson’s disease using quantitative susceptibility mapping

    P. Macdonald, E. Alushaj, N. Handfield-Jones, A. Khan, A. Owen (London, ON, Canada)

    Objective: To assess iron levels in dopaminergic midbrain nuclei using quantitative susceptibility mapping for identification of biomarkers of PD. Background: The midbrain dopaminergic system plays…
  • 2019 International Congress

    Effective deep brain stimulation co-modulate cross-frequency coupling

    S. Groppa, M. Glaser, N. Koirala, M. Bange, M. Muthuraman (Mainz, Germany)

    Objective: The disruption of pathological signals in the cortico-basal ganglia- network has been hypothesized as a mechanism of action of deep brain stimulation (DBS).  However,…
  • 2019 International Congress

    Neuronal Network Underlying Speech Difficulties in Parkinson’s Disease

    S. Polychronis, G. Pagano, VC. Suarez Contreras, T. Yousaf, M. Politis (London, United Kingdom)

    Objective: We aimed to investigate whether speech difficulties are associated with changes in cortical thickness. Background: Speech difficulties are a common debilitating feature of Parkinson’s…
  • 2019 International Congress

    Cortical cholinergic dysfunction correlates with microglial activation in the Substantia Innominata in patients with REM sleep behavior disorder

    K. Stær, A. Iranzo, M. Stokholm, K. østergaard, M. Eroles, M. Otto, K. Svendsen, A. Pla, D. Vilas, J. Santamaria, A. Møller, C. Gaig, P. Borghammer, D. Brooks, E. Tolosa, N. Pavese (Aarhus N, Denmark)

    Objective: To explore possible correlations between levels of microglial activation (neuroinflammation) in the Substantia Innominata (SI), the major source of cholinergic input to the cortex,…
  • 2019 International Congress

    Evaluation of Imidazoline 2 binding sites reflecting astroglia pathology in Huntington’s Disease: An in vivo [11C]BU99008 PET study

    H. Wilson, F. Niccolini, G. Dervenoulas, R. Tyacke, J. Myers, R. Gunn, D. Nutt, E. Rabiner, S. Tabrizi, M. Politis (London, United Kingdom)

    Objective: We aimed to evaluate the role of astroglia activation in Huntington’s disease gene expansion carriers (HDGECs) using [11C]BU99008 PET, a novel radioligand with high specificity and…
  • 2019 International Congress

    Park-Ease Trial: A Randomized Controlled Trial to Study the Efficacy of Exercises in Early-Stage Parkinson’s Disease

    R. Swarnakar, S. Wadhwa, S. V, V. Goyal, V. Sreenivas (New Delhi, India)

    Objective: To evaluate the efficacy of exercises in early-stage Parkinson’s Disease by observing improvement in motor symptoms assessed by Unified Parkinson’s Disease Rating Scale (UPDRS)…
  • 2019 International Congress

    Misdiagnosis in blepharospasm: the common imitators which should not be missed

    S. Desai, S. Thati, D. Desai (Anand, India)

    Objective: Blepharospasm is a focal dystonia whose diagnosis is completely clinical with no blood or imaging biomarker. We observed that sometimes, patients with other disorders…
  • 2019 International Congress

    Stiff-Person Syndrome and Limbic Encephalopathy Associated With GAD-antibody: A Case Report

    SL. Li, YM. Yang, HZ. Guan, XH. Wan, HT. Ren (Peking, China)

    Objective: To extend spectrum of glutamic acid decarboxylase(GAD) associated disorders by reporting a case Background: GADA associated disorders include a broad and clinically heterogeneous group…
  • 2019 International Congress

    Satisfaction with care in late stage Parkinson’s disease

    K. Rosqvist, P. Hagell, S. Iwarsson, M. Nilsson, P. Odin (Lund, Sweden)

    Objective: To assess satisfaction with care in patients with late stage Parkinson’s disease (PD) and to identify factors associated with patient satisfaction with care. Moreover,…
  • 2019 International Congress

    Characterization of impulsivity in Colombian patients with Huntington’s disease

    L. Colmenares, C. Rodriguez, W. Fernandez (Bogotá, Colombia)

    Objective: To describe impulsivity in patients with Huntington's disease using a self-report scale and through an objective test of the inhibition capacity. Describe the demographic…
  • « Previous Page
  • 1
  • …
  • 159
  • 160
  • 161
  • 162
  • 163
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley